What is the treatment for Mycoplasma (Mycoplasma) infections during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Mycoplasma infections during pregnancy should be treated with azithromycin as the first-line treatment, as recommended by the most recent guidelines 1. The treatment of Mycoplasma genitalium infection in pregnancy is crucial to prevent complications such as preterm birth, low birth weight, or postpartum endometritis.

  • The recommended treatment is typically azithromycin, which is considered safe during all trimesters of pregnancy 1.
  • The dosing schedule of azithromycin may vary, but a common regimen is 1 gram as a single dose or 500 mg on day 1 followed by 250 mg daily for 4 more days 2.
  • Alternative options, such as pristinamycin, may be considered for macrolide-resistant infections, but the safety data is inconsistent 1.
  • It is essential to complete the full course of antibiotics, even if symptoms improve, and to treat partners simultaneously to prevent reinfection.
  • Untreated mycoplasma infections during pregnancy can lead to severe complications, making prompt and effective treatment crucial 3, 4.
  • The infection is diagnosed through specific PCR testing, as standard cultures do not detect mycoplasma 5.
  • Macrolides like azithromycin are the preferred treatment option because mycoplasma bacteria lack cell walls, making them naturally resistant to common antibiotics like penicillins and cephalosporins that target cell wall synthesis 1, 2.

References

Research

Treatment of Mycoplasma genitalium infection in pregnancy: A systematic review of international guidelines.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2024

Research

Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013

Research

Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.